📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Neurovance

1.1 - Company Overview

Neurovance Logo

Neurovance

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of clinical-stage neuroscience drug development, having discovered and developed centanafadine (CTN) to help adults and children with ADHD.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Neurovance

SensoDetect Logo

SensoDetect

HQ: Sweden Website
  • Description: Provider of medical device technology to help detect mental illness.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full SensoDetect company profile →
Centrexion Therapeutics Logo

Centrexion Therapeutics

HQ: United States Website
  • Description: Provider of late clinical-stage biopharmaceutical therapies for chronic pain, including CNTX-4975, a synthetic trans-capsaicin injected directly into the site of pain to treat moderate to severe knee osteoarthritis, targeting the TRPV1 receptor to selectively inactivate local pain fibers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Centrexion Therapeutics company profile →
Inscopix Logo

Inscopix

HQ: United States Website
  • Description: Provider of neural activity imaging solutions for freely behaving subjects, enabling links between circuit dynamics and behavior. Offers the nVue dual-color system with expanded storage for longitudinal studies, the LScape module for wider field of view and longer working distance in cortical imaging, and Multicolor Data Processing software for streamlined miniscope analysis with PCA/ICA or CNMFe, filtering, and longitudinal registration.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Inscopix company profile →
Synergia Medical Logo

Synergia Medical

HQ: Belgium Website
  • Description: Provider of optoelectronic neurostimulation devices and platforms, including NAO.VNS for drug-resistant epilepsy via Vagus Nerve Stimulation, and technologies such as non-metallic encapsulation, fast wireless charging, custom optical leads, and miniaturized photovoltaic cells to advance therapies for chronic pain, Parkinson’s disease, epilepsy, sleep apnea, and depression.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Synergia Medical company profile →
Latigo Bio Logo

Latigo Bio

HQ: United States Website
  • Description: Provider of clinical-stage, non-opioid therapies for chronic pain, including LTGO-33, a selective NaV1.8 inhibitor, and a Nav1.8 pain program. Leverages ion channel expertise, human tissue and genetic data, a proprietary discovery engine, and multiparameter optimization to identify, validate, and optimize small-molecule candidates targeting pain-related channels.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Latigo Bio company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Neurovance

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Neurovance

2.2 - Growth funds investing in similar companies to Neurovance

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Neurovance

4.2 - Public trading comparable groups for Neurovance

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Neurovance

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Neurovance

What does Neurovance do?

Neurovance is a provider of clinical-stage neuroscience drug development, having discovered and developed centanafadine (CTN) to help adults and children with ADHD.

Who are Neurovance's competitors?

Neurovance's competitors and similar companies include SensoDetect, Centrexion Therapeutics, Inscopix, Synergia Medical, and Latigo Bio.

Where is Neurovance headquartered?

Neurovance is headquartered in United States.

How many employees does Neurovance have?

Neurovance has 1,000 employees 🔒.

When was Neurovance founded?

Neurovance was founded in 2010 🔒.

What sector and industry vertical is Neurovance in?

Neurovance is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Neurovance

Who are the top strategic acquirers in Neurovance's sector and industry

Top strategic M&A buyers and acquirers in Neurovance's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Neurovance?

Top strategic M&A buyers groups and sectors for Neurovance include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Neurovance's sector and industry vertical

Which are the top PE firms investing in Neurovance's sector and industry vertical?

Top PE firms investing in Neurovance's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Neurovance's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Neurovance's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Neurovance's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Neurovance include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Neurovance's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Neurovance?

The key public trading comparables and valuation benchmarks for Neurovance include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Neurovance for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Neurovance with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Neurovance's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Neurovance with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Neurovance's' sector and industry vertical?

Access recent funding rounds and capital raises in Neurovance's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Neurovance